Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIN1 | Q13526 | 1/20 | 0.47 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.44 |
| ▸ | CALCR | P30988 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.44 |
| ▸ | NPFFR1 | Q9GZQ6 | 2/20 | 0.44 |
| ▸ | NPFFR2 | Q9Y5X5 | 2/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.43 |
| ▸ | NPY1R | P25929 | 5/20 | 0.43 |
| ▸ | NPY4R | P50391 | 5/20 | 0.43 |
| ▸ | NPY2R | P49146 | 3/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.42 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | KDM5A | P29375 | 1/20 | 0.42 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.42 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13311924 | 0.96 | PIN1 (0.49) | PIN1RAMP3CALCRLCKOPRM1 | |
| SCHEMBL29483768 | 0.79 | TDP1 (0.56) | NPY5RNPY1RNPY4RNPY2R | |
| SCHEMBL14524247 | 0.79 | EPHA2 (0.48) | PIN1RAMP3CALCROPRM1OPRD1 | |
| SCHEMBL13311908 | 0.79 | TDP1 (0.61) | — | |
| SCHEMBL10358936 | 0.78 | LCK (0.50) | PIN1LCKOPRM1DRD3NMUR2 | |
| SCHEMBL14524231 | 0.77 | TDP1 (0.54) | — | |
| SCHEMBL13311852 | 0.77 | TDP1 (0.55) | NPY5RNPY1RNPY4RNPY2R | |
| SCHEMBL13311883 | 0.77 | TDP1 (0.57) | — | |
| SCHEMBL13311807 | 0.76 | TDP1 (0.56) | NPY5RNPY1RNPY4RNPY2R | |
| SCHEMBL13432796 | 0.76 | TDP1 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070078094-A1 | Guanidinium delivery carriers | NITTO DENKO CORPORATION (JP) | 2007-04-05 | — | — | US | disclosed |
| US-20070078094-A1 | Guanidinium delivery carriers | NITTO DENKO CORPORATION (JP) | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078094-A1 | Guanidinium delivery carriers | SLC2A9, SLC29A2, SLC2A4 | PIN1 3874/4885RAMP3 877/4885CALCR 2301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.